Bone Loss Drugs Increase Stroke Risk in Patients with Cancer

MARCH 21, 2011

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Article courtesy of http://www.onclive.com
 



Copyright© MD Magazine 2006-2017 Intellisphere, LLC. All Rights Reserved.